AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28168381 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg bolus and 2 mg/kg/h continuous infusion during the operation)
Number of subjects: 52
Study 28168381 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 52
Study 28168381 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 52
Study 25447615 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 0
Study 23461581 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal immunoglobulin (1000 IU, free of preservatives) plus intramuscular immunoglobulin (3000 IU)
Number of subjects: 120
Study 23461581 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular immunoglobulin (3000 IU, with preservative)
Number of subjects: 120
Study 21565663 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrective statements (text-based and pictorial)
Number of subjects: 239
Study 21565663 — intervention group
Group type: EXPERIMENTAL
Intervention: DOJ, Interveners, and emotive statements
Number of subjects: 239
Study 21565663 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotive statement
Number of subjects: 239
Study 19760991 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitor (PPI) Group
Number of subjects: 50
Study 19760991 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal Vagotomy Group
Number of subjects: 50
Study 19760991 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 50
Study 19760991 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid diet
Number of subjects: 50
Study 16572922 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg tablet formulation
Number of subjects: 80
Study 12611838 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 50
Study 12611838 — intervention group
Group type: COMPARATOR
Intervention: Parenting education control program
Number of subjects: 50
Study 10831943 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytoestrogens (PE) 80 mg/day of isoflavones
Number of subjects: 20
Study 10831943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9205015 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole hyperemia
Number of subjects: 25
Study 9205015 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal myocardium subtended by bypass grafts
Number of subjects: 25
Study 9205015 — intervention group
Group type: COMPARATOR
Intervention: Saphenous vein grafts
Number of subjects: 25
Study 9205015 — intervention group
Group type: COMPARATOR
Intervention: Internal mammary artery grafts
Number of subjects: 25
Study 9205015 — intervention group
Group type: COMPARATOR
Intervention: Venous grafts
Number of subjects: 25
Study 9205015 — intervention group
Group type: COMPARATOR
Intervention: Arterial grafts
Number of subjects: 25
Study 8221449 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP‐T vaccine mixed with DPT vaccine (combined in one injection)
Number of subjects: 433
Study 8221449 — intervention group
Group type: COMPARATOR
Intervention: PRP‐T vaccine given as separate, bilateral injections
Number of subjects: 433
Study 8221449 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups (PRP‐T and DPT vaccines)
Number of subjects: 433
Study 8221449 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP‐T vaccine mixed with DPT vaccine
Number of subjects: 433
Study 3112713 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (CFZ)
Number of subjects: 60
Study 3112713 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone (CFP)
Number of subjects: 60
Study 31213063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy targeting emotion regulation
Number of subjects: 48
Study 31213063 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment levels of child-reported emotion inhibition
Number of subjects: 48
Study 31213063 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment levels of parent and child-reported emotion regulation
Number of subjects: 48
Study 31213063 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment levels of behavioural and emotional symptom severity
Number of subjects: 48
Study 27988219 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-loss intervention with calorie-restricted diets and exercise guidance (approximate weight loss of 0.91 kg/wk)
Number of subjects: 40
Study 27988219 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased red meat consumption
Number of subjects: 40
Study 27988219 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased poultry intake
Number of subjects: 40
Study 27400912 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 1031
Study 27400912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1031
Study 24938224 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed (30 g of milled flaxseed per day for six months)
Number of subjects: 100
Study 24938224 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 100
Study 22643948 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical steroid drops applied with the Mygind technique for 8 weeks postoperatively
Number of subjects: 43
Study 22643948 — intervention group
Group type: COMPARATOR
Intervention: Topical steroid sprays for 8 weeks postoperatively
Number of subjects: 43
Study 20546812 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose sweetened fruit drink (SSD)
Number of subjects: 47
Study 20546812 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice (OJ)
Number of subjects: 47
Study 20546812 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-skimmed milk (M)
Number of subjects: 47
Study 20546812 — intervention group
Group type: COMPARATOR
Intervention: Calorie free (artificially sweetened) fruit drink (CTRL)
Number of subjects: 47
Study 18640074 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible-dose pregabalin (150-600 mg/d)
Number of subjects: 269
Study 18640074 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose pregabalin (300 mg/d)
Number of subjects: 269
Study 18640074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 18640074 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible-dose pregabalin
Number of subjects: 269
Study 18640074 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose pregabalin
Number of subjects: 269
Study 16398377 — intervention group
Group type: EXPERIMENTAL
Intervention: Suntouch radiant warmer
Number of subjects: 60
Study 16398377 — intervention group
Group type: COMPARATOR
Intervention: Forced-air warming
Number of subjects: 60
Study 12766124 — intervention group
Group type: EXPERIMENTAL
Intervention: Zofenopril
Number of subjects: 303
Study 12766124 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic patients
Number of subjects: 303
Study 12766124 — intervention group
Group type: COMPARATOR
Intervention: Diabetic patients
Number of subjects: 303
Study 10556869 — intervention group
Group type: EXPERIMENTAL
Intervention: 40/50 mg metrifonate
Number of subjects: 605
Study 10556869 — intervention group
Group type: EXPERIMENTAL
Intervention: 60/80 mg metrifonate
Number of subjects: 605
Study 10556869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 605
Study 8876303 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% estradiol
Number of subjects: 59
Study 8876303 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% estriol
Number of subjects: 59
Study 1579337 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg ticlopidine b.i.d. (49 patients)
Number of subjects: 100
Study 1579337 — intervention group
Group type: COMPARATOR
Intervention: Placebo (51 patients)
Number of subjects: 100
Study 4073083 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticarcillin plus clavulanic acid
Number of subjects: 85
Study 4073083 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin plus clindamycin
Number of subjects: 85
Study 31879857 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased fairness at the workplace (organizational justice)
Number of subjects: 7506
Study 31879857 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased fairness at the workplace (organizational justice)
Number of subjects: 7506
Study 31879857 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in organizational justice (distributive, procedural, interactional)
Number of subjects: 7506
Study 29413242 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-Eluting Balloon (DEB)
Number of subjects: 278
Study 29413242 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-Eluting Stent (DES)
Number of subjects: 278
Study 27182847 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management occupational therapy intervention program (SMOoTh)
Number of subjects: 31
Study 27182847 — intervention group
Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 31
Study 25378913 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 60
Study 25378913 — intervention group
Group type: COMPARATOR
Intervention: Conventional intraoperative fluid management (Control)
Number of subjects: 60
Study 23301466 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture + medication
Number of subjects: 102
Study 23301466 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional acupuncture + medication
Number of subjects: 102
Study 23301466 — intervention group
Group type: COMPARATOR
Intervention: Medication (seroxat)
Number of subjects: 102
Study 23301466 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 102
Study 20658791 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 14
Study 20658791 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 14
Study 20658791 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine
Number of subjects: 14
Study 18215590 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 4600
Study 18215590 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Number of subjects: 4600
Study 18215590 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Aspirin and Tranexamic Acid
Number of subjects: 4600
Study 18215590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4600
Study 15825877 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive detection using arterio-oscillo-graphy
Number of subjects: 51
Study 12730088 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen (1000 mg/d)
Number of subjects: 45
Study 12730088 — intervention group
Group type: EXPERIMENTAL
Intervention: aspirin (75 mg/d)
Number of subjects: 45
Study 12730088 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac (150 mg/d)
Number of subjects: 45
Study 12730088 — intervention group
Group type: EXPERIMENTAL
Intervention: rofecoxib (50 mg/d)
Number of subjects: 45
Study 12564001 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopy group (20 eyes)
Number of subjects: 30
Study 12564001 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 eyes)
Number of subjects: 30
Study 8764424 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical mastectomy (mastectomy and formal axillary dissection with pectoral muscle excision)
Number of subjects: 95
Study 8764424 — intervention group
Group type: COMPARATOR
Intervention: Simple mastectomy (mastectomy without axillary dissection if nodes were not clinically palpable, or local excision of the nodes if they were)
Number of subjects: 95
Study 1801542 — intervention group
Group type: EXPERIMENTAL
Intervention: deprenyl, 10 mg/day
Number of subjects: 800
Study 1801542 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 800
Study 1801542 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-tocopherol, 2,000 I.U./day
Number of subjects: 800
Study 7047649 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamycin (single injection one hour before surgery)
Number of subjects: 47
Study 7047649 — intervention group
Group type: COMPARATOR
Intervention: Untreated group (no antibiotic)
Number of subjects: 47
Study 30922997 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide orodispersible tablet (BOT) 1 mg twice daily; n = 59
Number of subjects: 88
Study 30922997 — intervention group
Group type: COMPARATOR
Intervention: Placebo; n = 29
Number of subjects: 88
Study 30646295 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enrollment strategy using advance consent
Number of subjects: 52
Study 26846607 — intervention group
Group type: COMPARATOR
Intervention: NSPT alone
Number of subjects: 87
Study 26846607 — intervention group
Group type: EXPERIMENTAL
Intervention: NSPT + Nd:YAG laser therapy
Number of subjects: 87
Study 24853958 — intervention group
Group type: EXPERIMENTAL
Intervention: Humerus interlocking nail (HIL)
Number of subjects: 40
Study 24853958 — intervention group
Group type: COMPARATOR
Intervention: Locking compression plate (LCP)
Number of subjects: 40
Study 22583135 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin testing with various CM (iobitridol, iomeprol, iodixanol, iohexol, ioversol, iopramide, ioxaglate)
Number of subjects: 161
Study 22583135 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug provocation test (DPT)
Number of subjects: 161
Study 22583135 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin testing and DPT combined
Number of subjects: 161
Study 20466427 — intervention group
Group type: EXPERIMENTAL
Intervention: Iris-fixated foldable posterior chamber IOL (PCIOL; AcrySof MA60AC)
Number of subjects: 16
Study 20466427 — intervention group
Group type: EXPERIMENTAL
Intervention: Iris-claw anterior chamber IOL (ACIOL; Artisan)
Number of subjects: 16
Study 20466427 — intervention group
Group type: COMPARATOR
Intervention: Both groups (PCIOL and ACIOL)
Number of subjects: 16
Study 20466427 — intervention group
Group type: EXPERIMENTAL
Intervention: Iris-fixated foldable posterior chamber IOL (PCIOL)
Number of subjects: 16
Study 17177272 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrophage colony-stimulating factor
Number of subjects: 0
Study 17177272 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval estimator using tanh(−1)(x) transformation
Number of subjects: 0
Study 17177272 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization-based interval estimator
Number of subjects: 0
Study 17177272 — intervention group
Group type: EXPERIMENTAL
Intervention: All interval estimators considered
Number of subjects: 0
Study 16101620 — intervention group
Group type: EXPERIMENTAL
Intervention: Managed Ventricular Pacing (MVP)
Number of subjects: 181
Study 16101620 — intervention group
Group type: COMPARATOR
Intervention: DDD/R
Number of subjects: 181
Study 11908467 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg once daily for 8 weeks
Number of subjects: 4
Study 10456811 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (2.5, 5.0, 7.5 microg kg(‐1) min(‐1))
Number of subjects: 8
Study 10456811 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramid (10 mg i.v. bolus during dopamine infusion)
Number of subjects: 8
Study 10456811 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramid (10 mg i.v. bolus before dopamine infusion)
Number of subjects: 8
Study 7615484 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 24
Study 7615484 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 15 mg
Number of subjects: 24
Study 7615484 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.08% peak blood alcohol concentration)
Number of subjects: 24
Study 7615484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2475056 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular therapy with vitamin D (600,000 IU)
Number of subjects: 250
Study 2475056 — intervention group
Group type: COMPARATOR
Intervention: Oral vitamin D
Number of subjects: 250
Study 31915800 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tsDCS
Number of subjects: 2
Study 31915800 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tsDCS
Number of subjects: 2
Study 31915800 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 2
Study 29161371 — intervention group
Group type: EXPERIMENTAL
Intervention: MI Paste Plus (MPP), applied once a day at bedtime for 12 months
Number of subjects: 51
Study 29161371 — intervention group
Group type: COMPARATOR
Intervention: Control paste, applied once a day at bedtime for 12 months
Number of subjects: 51
Study 28159565 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Port (SP) sleeve gastrectomy
Number of subjects: 30
Study 28159565 — intervention group
Group type: COMPARATOR
Intervention: Conventional Multiport Laparoscopy (LAP) sleeve gastrectomy
Number of subjects: 30
Study 25154423 — intervention group
Group type: EXPERIMENTAL
Intervention: General Accepted Practices (GAPs) for HHD access care training by nurses
Number of subjects: 19
Study 25154423 — intervention group
Group type: EXPERIMENTAL
Intervention: General Accepted Practices (GAPs) for HHD access care adherence
Number of subjects: 19
Study 25154423 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on identification of signs and symptoms of infection
Number of subjects: 19
Study 25154423 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence to GAP
Number of subjects: 19
Study 25154423 — intervention group
Group type: EXPERIMENTAL
Intervention: Practices without GAPs
Number of subjects: 19
Study 23302322 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning supported Train-the-Trainer program for guideline application, 1-day training, 60-minute e-learning module
Number of subjects: 936
Study 23302322 — intervention group
Group type: COMPARATOR
Intervention: Traditional dissemination of the guideline (manuals, books, conferences, internet, reviews)
Number of subjects: 936
Study 21266057 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (150 mg bid)
Number of subjects: 540
Study 21266057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 19143855 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumiracoxib 400 mg once daily (qd)
Number of subjects: 406
Study 19143855 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily (bid)
Number of subjects: 406
Study 17166990 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART (budesonide/formoterol 80/4.5 microg qd maintenance plus additional inhalations for symptom relief)
Number of subjects: 341
Study 17166990 — intervention group
Group type: COMPARATOR
Intervention: Fixed-dose budesonide (320 microg qd)
Number of subjects: 341
Study 17166990 — intervention group
Group type: COMPARATOR
Intervention: Fixed-dose combination (budesonide/formoterol 80/4.5 microg qd)
Number of subjects: 341
Study 14624410 — intervention group
Group type: EXPERIMENTAL
Intervention: Portfolio diet (n=13)
Number of subjects: 25
Study 14624410 — intervention group
Group type: COMPARATOR
Intervention: Low-saturated fat diet (n=12)
Number of subjects: 25
Study 10809032 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg once daily intravenously followed by 500 mg once daily orally)
Number of subjects: 145
Study 10809032 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime plus erythromycin (750 mg every 8 hours intravenously followed by 500 mg twice daily orally for cefuroxime and 500-1000 mg every 6 hours for erythromycin)
Number of subjects: 145
Study 10809032 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime plus erythromycin
Number of subjects: 145
Study 10809032 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 145
Study 8892000 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 1426224 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized lignocaine
Number of subjects: 54
Study 1426224 — intervention group
Group type: COMPARATOR
Intervention: Sprayed lignocaine
Number of subjects: 54
Study 3871477 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemophilus influenzae type b capsular polysaccharide‐diphtheria toxoid conjugate vaccine (PRP‐D)
Number of subjects: 60
Study 3871477 — intervention group
Group type: COMPARATOR
Intervention: Haemophilus influenzae type b capsular polysaccharide vaccine (PRP)
Number of subjects: 60
Study 3871477 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP-D
Number of subjects: 60
Study 31176532 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial proportions from frontal photographs
Number of subjects: 800
Study 29038966 — intervention group
Group type: EXPERIMENTAL
Intervention: Case Management with Community Health Worker Support (CM+CHW)
Number of subjects: 207
Study 29038966 — intervention group
Group type: EXPERIMENTAL
Intervention: Case Management alone (CM)
Number of subjects: 207
Study 29038966 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 207
Study 24612825 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 0
Study 24612825 — intervention group
Group type: COMPARATOR
Intervention: Health-Enhancement Program (HEP)
Number of subjects: 0
Study 23152592 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal administration of oxytocin (OXT)
Number of subjects: 100
Study 23152592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 18651213 — intervention group
Group type: EXPERIMENTAL
Intervention: Male circumcision intervention
Number of subjects: 0
Study 18651213 — intervention group
Group type: EXPERIMENTAL
Intervention: Scale to measure sexual risk behavior
Number of subjects: 0
Study 18622797 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable Pivotal cutting blocks
Number of subjects: 40
Study 18622797 — intervention group
Group type: COMPARATOR
Intervention: Conventional fixed navigation cutting blocks
Number of subjects: 40
Study 16259688 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular sessions with a physiotherapist (intervention arm)
Number of subjects: 87
Study 16259688 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no information about physiotherapy sessions)
Number of subjects: 87
Study 12127381 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance of lightweight (BMI <15th percentile)
Number of subjects: 5098
Study 12127381 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal-weight children who became overweight
Number of subjects: 5098
Study 12127381 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavier children at age 11 years
Number of subjects: 5098